Hair care

Posts

Global Anti-dandruff Agent Ingredients Market

Global Anti-dandruff Agent Ingredients Market

Global Anti-dandruff Agent Ingredients Market

Market Analysis and Insights: Global Anti-dandruff Agent Ingredients Market

The global Anti-dandruff Agent Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Anti-dandruff Agent Ingredients Scope and Segment

The global Anti-dandruff Agent Ingredients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-dandruff Agent Ingredients market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

By the product type, the market is primarily split into

Silicone Free

Silicone Type

By the end-users/application, this report covers the following segments

Bleaches, Dyes & Colors Products

Conditioners & Detangling Products

Hair Gels

Shampoos

Styling/Hair Foams

Others

Competitive Landscape:

The report provides a list of all the key players in the Anti-dandruff Agent Ingredients market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product developments, research, and Developments, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.

The Anti-dandruff Agent Ingredients key manufacturers in this market include:

CLR Berlin

Lipoid Kosmetik

Minasolve

AQIA

Apara International

Aromtech Oy

BASF

Global Anti-dandruff Agent Ingredients Market

Source

Recent Posts

Global Anti-dandruff Agent Ingredients Market

Global Anti-dandruff Agent Ingredients Market

Global Anti-dandruff Agent Ingredients Market

Market Analysis and Insights: Global Anti-dandruff Agent Ingredients Market

The global Anti-dandruff Agent Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Anti-dandruff Agent Ingredients Scope and Segment

The global Anti-dandruff Agent Ingredients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-dandruff Agent Ingredients market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

By the product type, the market is primarily split into

Silicone Free

Silicone Type

By the end-users/application, this report covers the following segments

Bleaches, Dyes & Colors Products

Conditioners & Detangling Products

Hair Gels

Shampoos

Styling/Hair Foams

Others

Competitive Landscape:

The report provides a list of all the key players in the Anti-dandruff Agent Ingredients market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product developments, research, and Developments, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.

The Anti-dandruff Agent Ingredients key manufacturers in this market include:

CLR Berlin

Lipoid Kosmetik

Minasolve

AQIA

Apara International

Aromtech Oy

BASF

Global Anti-dandruff Agent Ingredients Market

Source

Recent Posts

Robotic Hair Transplant System

Robotic Hair Transplant System

Robotic Hair Transplant System Market

Alopecia or hair loss is a chronic dermatology disease in which there is either partial or complete loss of hair from the scalp and other parts of the body. According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and 147 million worldwide have developed alopecia at some point in time.

Strong family history is one of the main reasons contributing to pattern baldness or androgenic alopecia in both males and females.

As estimated by the International Society of Hair Restoration Surgery (ISHRS), more than 35 million men in the U.S. currently suffer from male pattern baldness. ARTAS robotic hair transplant systems make the hair translation procedure more effective and less painful.

The ARTAS robotic hair transplant system is a computer-assisted equipment use to improve the quality of follicle. It also enhances the quality of the most challenging Follicle Extraction Unit (FUE).

Various components of an ARTAS robotic hair transplant system are image-guided robotic arm, small dermal punches and a computer interface. The robot is guided by a 3-D imaging software and the cameras. The device removes the hair follicle at a rate of 1,000 per hour.

The FUE procedure involves removing hair from the donor region of the scalp and then implanting it into the recipient site. The separation of the follicular units from the donor tissue is a tedious, repetitive and labour intensive process. The FUE process requires great precision to prevent damage to follicular units.

The ARTAS robotic hair transplant system has significantly increased the accuracy of the FUE procedure. The ARTAS robotic hair transplant system reduces harvesting time and minimizes any damage to hair follicles with its efficacy and great precision. The ARTAS robotic hair transplant system also improves the chances of graft survival. It is also far more comfortable than traditional and more invasive hair restoration processes.

Robotic Hair Transplant System Market: Drivers and Restraints

Increasing prevalence of various dermatological related disorders will drive the robotic hair transplant system market during the forecast period. Unhealthy lifestyle patterns and an increase in stress levels will further contribute towards the growth of hair restoration treatment and robotic hair transplant systems market.

Genetic and other environmental factors increase baldness among men and women. Technologically improved and minimally invasive transplant treatment methods will increase the growth of the robotic hair transplant system market during the forecast period. High adoption among people of young age to enhance their appearance will further fuel the overall market of robotic hair transplant systems.

However, high cost and various side effects associated with the treatment, such as an itchy scalp, hair thinning, etc., might hinder the growth of the robotic hair transplant system market during the forecast period.

Robotic Hair Transplant System Market: Segmentation

The robotic hair transplant system market can be segmented on the basis of end-user and region. Based on end-user, the hair transplant system market is segmented as:

  • Dermatology Clinics
  • Hospitals

Robotic Hair Transplant System Market: Overview

The ARTAS robotic hair transplant system market is growing at a fast pace as these systems are quite efficient and make the entire procedure more comfortable.

Higher adoption of robotic hair transplant treatment over traditional, more time-consuming treatments has given a boost to the overall market of ARTAS robotic hair transplant system.

Robotic Hair Transplant System Market: Regional Outlook

Geographically, the global robotic hair transplant system market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America dominates the robotic hair transplant system market due to the rapid technological advancements and better healthcare facilities.

It is followed by Europe because of high adoption among end-users. Asia-Pacific is expected to witness fast expansion in robotic hair transplant system market due to increasing prevalence of skin-related disorders and growth in healthcare infrastructure. The Middle East and African regions will witness sluggish growth because of a lack of awareness among people and the high cost of the treatment.

Robotic Hair Transplant System Market: Key Players

Restoration robotics Inc. is the manufacturer of ARTAS robotic hair transplantation systems, which was FDA approved in 2011.

Other manufacturers are also focusing on developing other robotic hair transplant systems.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Peru
    • Rest of LATAM
  • Europe
    • EU – 4 (Germany, France, Italy, Spain)
    • UK
    • BENELUX (Belgium, Netherlands, Luxemburg)
    • NORDIC (Norway, Denmark, Iceland, Sweden)
    • Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
    • Rest of Europe
  • CIS & Russia
  • Japan
  • APEJ
    • Greater China
    • India
    • Korea
    • ASEAN Countries
    • Rest of APEJ
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Iran
    • Israel
    • South Africa
  • Rest of MEA

Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Robotic Hair Transplant System Market

Source

Recent Posts

Hair Transplant Market

Hair Transplant System Market

Global Hair Transplant System Market

According to Apex Market Research, the Hair Transplant System market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Hair Transplant System Market delivers detailed analysis covering major regional trends, market dynamics, and offer the country-level market value of Hair Transplant System industry.

Some of the major aspects considered during the course of research comprise the definition of the product, classification of the product, industry structure, different participants in the Hair Transplant System ecosystem, etc.

The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for the individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Hair Transplant System market.

The following manufacturers are covered in this report:

  • Bosley
  • Bernstein Medical
  • Limmer Hair Transplant Center
  • Medicamat
  • GetFUE Hair Clinics
  • Hairline
  • Acibadem Healthcare Group
  • HLC Hair Transplant Center Turkey
  • Hairline Studios
  • Vinci Medical Group

The report estimates on the Hair Transplant System market economy trend, market numbers (Mn/Bn USD) and CAGR from 2020-2028, considering 2019 as the base year. A global Hair Transplant System market report consist of all leading industry players, Hair Transplant System business sections, company profile, revenue supply by Hair Transplant System industry sections, global Hair Transplant System market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result, numerous economies around the world experienced a severe economic downturn. Since early 2020, the

Hair Transplant System market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Hair Transplant System market in years 2020 and 2019 and moreover it offers a forecast for the Covid-19 period from 2020 to 2028.

The report provides COVID-19 impact on Hair Transplant System market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Hair Transplant System market.

Report Opportunity: Global Hair Transplant System Market

This report delivers an analytical examination of the Hair Transplant System market summarized in broad sections such as

  1. Hair Transplant System Market Summary
  2. Key Commercial Growths in the Hair Transplant System Industry
  3. Market Dynamics Affecting the Hair Transplant System Industry
  4. Important Market Trends and Future Development Scenario of the Hair Transplant System Market
  5. Hair Transplant System Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Hair Transplant System Industry
  7. The positioning of Main Market Players in the Hair Transplant System Industry
  8. Hair Transplant System Market Revenue and Forecast, by Application, 2018 – 2028
  9. Hair Transplant System Market Revenue and Forecast, by End-use, 2018 – 2028
  10. Hair Transplant System Market Revenue and Forecast, by Geography, 2018 – 2028

Hair Transplant System Market Segmentation:

The report provides a detailed examination of the Hair Transplant System market on the basis of various segments such as type, application and end-use industry. The Hair Transplant System market is segmented as follows:

Hair Transplant System Market, by Type:

  • Follicular Unit Strip Surgery (FUSS)
  • Follicular Unit Transplantation (FUT)
  • Follicular Unit Extraction (FUE)

Hair Transplant System Market, by Application:

  • Hospitals
  • Specialized Clinics
  • Ambulatory Surgical Centers

Geographic Coverage

The report on the Hair Transplant System market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Hair Transplant System Market Revenue and Forecast

  • U.S.
  • Canada

Europe Hair Transplant System Market Revenue and Forecast

  • UK
  • Germany
  • France
  • Rest of Europe

Asia Pacific Hair Transplant System Market Revenue and Forecast

  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Hair Transplant System Market Revenue and Forecast

  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Hair Transplant System Market Revenue and Forecast

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Global Hair Transplant System Market

Source

Recent Posts

Global Alopecia Treatment Market

Androgenetic Alopecia Treatment Market

Androgenetic Alopecia Treatment Market Analysis

Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors. The increasing incidence of androgenetic alopecia is expected to boost the market growth.

According to the National Center for Biotechnology Information (NCBI), in August 2015, the global prevalence of severe androgenetic alopecia (AGA) was 15.33% overall and varied significantly by geographical region. The risk of having severe androgenetic alopecia (AGA) increased by 1.092 for per year for the 30 and 40 age group.

The global androgenetic alopecia treatment market is estimated to be valued at US$ 1,607.47 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).

Product development and ongoing clinical trials are expected to propel the growth of the global androgenetic alopecia treatment market.

Development of drugs for androgenetic alopecia treatment is expecting to boost the market growth over the forecast period. For instance, Cairo University is conducting a clinical trial of topical Cetirizine for the treatment of androgenetic alopecia in females.

The trial is in Phase II/III evaluating the efficacy and tolerability of topical cetirizine in female patients with androgenetic alopecia (AGA). This interventional trial started in February 2020 and the study expected completed in December 2021.

However, side effects of androgenetic alopecia treatment are expected to hinder the market growth. According to the US Pharmacist, a clinically-focused pharmacy publication, published an article- Treatment Options for Androgenetic Alopecia, in 2018 that medication used in for the treatment of androgenetic alopecia has many side effects. For example, topical Minoxidil can cause local erythema and pruritus and Finasteride can cause dizziness, orthostatic hypotension and others.

Report Coverage Details

Base Year:
2019

Market Size in 2020:
US$ 1,607.47 Mn

Historical Data for:
2016 to 2019

Forecast Period:
2020 to 2027

Forecast Period 2020 to 2027 CAGR:
5.3%

2027 Value Projection:
US$ 2,298.34 Mn

Geographies covered:

  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa

Segments covered:

  • By Drug Type: Topical Agents, 5 AR Inhibitors, Others.
  • By Route of Administration: Oral, Topical.
  • By Gender: Male, Female.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Companies covered:

Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd.

Growth Drivers:

  • Rising incidence of androgenetic alopecia
  • Product development and ongoing trials for treatment of androgenetic alopecia

Restraints & Challenges:

  • Side effects of androgenetic alopecia treatment
  • Alternative treatment for androgenetic alopecia treatment

Research and development of treatment for androgenetic alopecia in North America is expected to boost the market growth.

North America is expected to hold dominant position in the global androgenetic alopecia treatment market owing to research and development of treatments for androgenetic alopecia in the region. For instance, on June 4, 2020, Follica, Inc., a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, and other related conditions, announced positive feedback from the U.S. Food and Drug Administration (FDA) for its FOL-004 Phase II released in December 2019. The company advanced its lead program, FOL-004 into Phase III development, following a successful safety and efficacy optimization study for the treatment of hair loss in male androgenetic alopecia.

Global Androgenetic Alopecia Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

Nationwide lockdowns resulting from COVID-19 in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.

The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.

As a result, the impact of the COVID-19 pandemic is also expected to limit the growth of the global androgenetic alopecia treatment drugs market during the forecast period.

Key Players

Major players operating in the global androgenetic alopecia treatment market are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. among others.

Androgenetic Alopecia Treatment Market Analysis

Source

Recent Posts

Follica Announces Positive Topline Data from Clinical Study in Male Androgenetic Alopecia

Follica Announces Pilot Study for Female Pattern Hair Loss

Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology

Follica, a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial ageing and other related conditions, today announced the publication of a pilot study evaluating scalp skin disruption to promote hair growth in female pattern hair loss (FPHL) in International Journal of Women’s Dermatology.

The treatment promoted hair growth over a four-month course of treatment.

The pilot study, led by Maryanne M. Senna, M.D., an assistant professor of dermatology at Harvard Medical School, enrolled 11 women with mild to moderate FPHL who had been on stable existing treatments for six or more months.

Patients underwent six treatments with the Follica proprietary Hair Follicle Neogenesis (HFN) device and application of a topical on-market drug on non-treatment days.

The scalp treatments with the HFN device, which last just a few minutes, stimulate stem cells and enable the growth of new hair follicles. A topical drug is then applied to enhance efficacy by thickening new hair follicles and hair on the scalp. The study endpoints included photographs, physician-documented Sinclair score and patient-reported improvement.

At the end of the study, 10 out of the 11 patients reported perceived improvement in hair growth and all 11 improved on their physician-graded Sinclair scores. Average improvement on the Sinclair scale, which runs from stage 1 to stage 5, was one full stage. The adverse events reported were mild and self-resolving, and all women completed the course of treatment. Although the sample size was limited, the study’s authors called the results encouraging and called for larger studies.

“Around 40 per cent of women show signs of hair loss by age 50, and for many, this starts at an earlier age. Although many women struggle with this condition, there are very few effective treatment options available, and all too often, investigational therapies are tested primarily in men,” said Dr Senna, who directs the hair loss clinic at Massachusetts General Hospital.

“This pilot study was small but encouraging, as almost all of the patients reported meaningful improvements. This was especially welcome since many of these women had tried other treatments without success. There’s a significant treatment gap for women in this field, and it’s terrific to see new approaches with the potential to close that gap. I look forward to additional research on how the Follica device could address female pattern hair loss.”

“This study demonstrates the potential of our regenerative approach at Follica, which is intended to create an embryonic window in adult skin, essentially allowing new follicles and new hair to form from epithelial stem cells. It confirms that, while our treatment may not yet be optimized for females, the mechanism of action has the potential to address both male and female androgenetic alopecia and makes clear that the device works well with longer hair as well as shorter hair,” said Jason Bhardwaj, CEO of Follica. “We’re excited to continue advancing our technology as we work to bring effective new treatment options to both men and women.”

Follica plans to advance its lead program into Phase 3 development in 2021, following a successful safety and efficacy optimization study for the treatment of hair loss in male androgenetic alopecia and a successful meeting with the Food and Drug Administration at the conclusion of the Phase 2 study.

The optimization study in male androgenetic alopecia was designed to select the optimal treatment regimen using Follica’s proprietary device in combination with a topical drug and successfully met its primary endpoint. The selected treatment regimen demonstrated a statistically significant 44 per cent improvement of non-vellus (visible) hair count after three months of treatment compared to baseline (p < 0.001, n = 19).

About Follica

Follica is a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial ageing and other related conditions. Founded by PureTech (LSE: PRTC, Nasdaq: PRTC), a co-inventor of the current platform and a group of world-renowned experts in hair follicle biology and regenerative medicine, Follica’s experimental treatment platform is designed to induce an embryonic window via a device with optimized parameters to initiate hair follicle neogenesis, the formation of new hair follicles from epithelial (skin) stem cells.

This process is enhanced through the application of a topical compound. Follica completed a safety and efficacy optimization study in 2019, and its Phase 3 registration program in male androgenetic alopecia is expected to begin in 2021. Follica’s technology is based on work originating from the University of Pennsylvania that has been further developed by Follica’s internal program. Follica’s extensive IP portfolio includes IP exclusively licensed from the University of Pennsylvania as well as Follica-owned IP.

Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology

Source

Recent Posts

Global Alopecia Treatment Market

Global Alopecia Treatment Market

Global Alopecia Treatment Market – Industry Trends and Forecast to 2027

Market Analysis and Insights: Global Alopecia Treatment (Hair Loss) Market

The alopecia treatment (hair loss) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.0% in the forecast period of 2020 to 2027 and is expected to reach USD 5,461.35 million by 2027. The rising prevalence of alopecia (hair loss) globally and extensive research & development activity in alopecia treatment (hair loss) are the major drivers which propelled the demand of the alopecia treatment (hair loss) market in the forecast period.

Alopecia treatment comprises features such as increasing need for an effective treatment for alopecia (hair loss) which will impact in launching new products by the manufacturers into the alopecia treatment (hair loss) market which enhance its demand as well as rising pharmaceutical industries initiatives leads to the alopecia treatment (hair loss) market growth.

Currently, various research & clinical studies are going on which is expected to create a competitive advantage for manufacturers to develop new and innovative alopecia treatment (hair loss) market. Moreover, these clinical programmes are also expected to provide various other opportunities in the alopecia treatment (hair loss) market. However, lack of awareness in rural countries and high cost of treatment is expected to restraint the alopecia treatment (hair loss) market growth in the forecast period.

The alopecia treatment (hair loss) market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the alopecia treatment (hair loss) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Alopecia Treatment (Hair Loss) Market Scope and Market Size

The alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end-user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of disease type, the alopecia treatment (hair loss) market is segmented into non-cicatricial alopecia, cicatricial alopecia, traction alopecia and others. In 2020, the non‒cicatricial alopecia segment is dominating the alopecia treatment (hair loss) market as non‒cicatricial alopecia has the highest prevalence rate across the globe and affects a majority of the population.
  • On the basis of treatment, the alopecia treatment (hair loss) market is segmented into localized therapies, systemic therapies, medical devices and herbal treatment. In 2020, localized therapies segment is dominating the alopecia treatment (hair loss) market due to first-line treatment to reduce the symptoms of alopecia and increase the hair growth.
  • On the basis of gender, the alopecia treatment (hair loss) market is segmented into male and female. In 2020, the male segment is dominating the alopecia treatment (hair loss) market due to the large number of male population affected by the androgenetic alopecia.
  • On the basis of form, the alopecia treatment (hair loss) market is segmented into oral, topical and parenteral. In 2020, the topical segment is dominating the alopecia treatment (hair loss) market as a topical form offers patients with huge compliance and high satisfaction.
  • On the basis of end-user, the alopecia treatment (hair loss) market is segmented into hospitals, home healthcare and dermatology centres. In 2020, dermatology centres segment is dominating the alopecia treatment (hair loss) market because alopecia is a dermatology related disorder and required innovative treatment solutions for hair loss.
  • On the basis of the distribution channel, the alopecia treatment (hair loss) market is segmented into direct tender, retail sales and pharmacies. In 2020, pharmacies segment is dominating the alopecia treatment (hair loss) market because, for the treatment of alopecia or hair loss, majority of the formulation are available on OTC, which do not require a prescription and also offers patients with instant gratification.

Global Alopecia Treatment (Hair Loss) Market Country Level Analysis

Global alopecia treatment (hair loss) market is analyzed and market size information is provided by country, disease type, treatment, gender, form, end-user and distribution channel as referenced above.

The countries covered in the alopecia treatment (hair loss) market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of the Middle East and Africa.

Non‒cicatricial alopecia segment in North America region is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 since it is the most common form of alopecia and people with alopecia aerate affects approximately 6.8 million people in the U.S. Japan is leading the growth of the Asia-Pacific alopecia treatment (hair loss) market and non‒cicatricial alopecia segment is dominating in the region due to rise in prevalence of alopecia and rising usage of hair care therapies for the treatment. The non‒cicatricial alopecia segment in Germany is dominating the European alopecia treatment (hair loss) market owing to the increasing demand for effective treatment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Continuous Increasing Awareness for Alopecia Treatment (Hair Loss) is boosting the Alopecia Treatment (Hair Loss) Market Growth

Alopecia treatment (hair loss) market also provides you with detailed market analysis for every country growth in alopecia treatment (hair loss) industry with alopecia treatment (hair loss) drugs sales, the impact of advancement in the alopecia treatment (hair loss) technology and changes in regulatory scenarios with their support for the alopecia treatment (hair loss) market. The data is available for the historic period 2010 to 2018.

Competitive Landscape and Alopecia Treatment (Hair Loss) Market Share Analysis

Alopecia treatment (hair loss) market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to alopecia treatment (hair loss) market.

The major companies which are dealing in the global alopecia treatment (hair loss) market report are Alès Groupe, Gerolymatos International SA, iGrow Laser, Lexington Intl., LLC., Curallux, LLC., Follicum AB, HCell Inc., Freedom Laser Therapy, Inc., Taisho Pharmaceutical Holdings Co., Ltd., Vita-Cos-Med Klett-Loch GmbH, Vitabiotics Ltd., WOCKHARDT, Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceuticals Industries Ltd.), Pfizer Inc., Par Pharmaceutical (a subsidiary of Endo International plc), GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., Abbott, Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila), Johnson & Johnson Services, Inc., Cipla Inc., Sun Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.), Aurobindo Pharma, Perrigo Company plc, Viviscal Limited (a subsidiary of Church & Dwight Co., Inc.), Dr. Kurt Wolff GmbH & Co. KG, Nanogen, Labo International S.r.l., Watermans, WON TECH Co., Ltd., PureTech among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the alopecia treatment (hair loss) market.

For instance,

  • In March 2018, Johnson & Johnson Services, Inc. teamed up with JW Pharmaceutical to enhance the sales of its product which is Rogaine, a hair loss treatment containing minoxidil. JW Pharmaceutical has signed an exclusive distributorship agreement with J&J in November 2017. Rogaine is FDA approved hair loss treatment and is considered a top-selling hair loss treatment. This initiative allowed the company to earn more product sales which has boosted the company’s overall revenue.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the alopecia treatment (hair loss) market which also provides the benefit for the organization to improve their offering for alopecia treatment (hair loss).

Customization Available: Global Alopecia Treatment (Hair Loss) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Global Alopecia Treatment Market – Industry Trends and Forecast to 2027

Source

Recent Posts

link between COVID -19 and hairloss

link between COVID -19 and hairloss

Dr Batra’s explains the recently discovered link between COVID -19 and hairloss

According to the International Journal of Dermatology and the US National Library of Medicine (NCBI), hair loss has been found to be a late-onset symptom of COVID-19 with almost 25% of patients reporting the issue.

The pandemic didn’t just affect the near and dear ones of those inflected by the virus, according to the New York Times, the pandemic also gave rise to incidents of stress-induced hair loss due to the uncertainty and stress of the times.

With the expertise of over 400 trained trichologists and homoeopaths, Dr Batra’s – the leading chain of homoeopathic clinics across the world, shed light on the reasons behind hair loss during the pandemic.

During the Pandemic, a spike in 3 different types of hair loss was noticed, namely:

  • Telogen effluvium: Is acute hair loss that is experienced when the body goes through physical trauma such as illness, pregnancy or even a crash diet. According to a study on patients in the US, 33% of COVID-19 survivors experienced Telogen effluvium hair loss. A COVID-19 survivor experiences this type of acute hair loss due to the body’s weakness from the illness.
    • Signs: If one is losing much more hair than usual (normal hair loss is 80-100 strands a day) or see visible clumps of hair on the pillow, brush or bathroom drain, then they can have Telogen Effluvium.
  • Alopecia Areata: Is an autoimmune disease that is known to be triggered in response to mental stress.
    • Signs: One will probably notice a bald spot or patch of hair loss in one or multiple areas of the head. These bald spots can appear very quickly and can rapidly multiply. A large increase in cases of Alopecia Areata was seen in patients due to financial and job security stress that emanated from the pandemic.
  • Trichotillomania: A type of hair loss that is caused when the patient pulls their own hair out, usually in response to emotional stress. This condition is 6 times more prevalent in women and is seen in teenagers between the ages of 14-17.
    • Signs: As people with this illness tend to pull their hair out from the roots, it can lead to bald patches on their heads, eyebrows and other parts of the body. Since the hair is pulled out, broken hair of different lengths can be a tell tale sign of this type of hair loss. The incidence of trichotillomania during the pandemic increased hugely in teenagers due to emotional stressors such as having to socially distance from their friends and due to anxiety of the future.

Commenting on the surge in hair loss cases during the Pandemic, Dr Akshay Batra, Vice-Chairman and Managing Director, Dr Batra’s Group of Companies and the 1st Indian President of The Trichological Society, London; said, “The mental, physical and emotional rollercoaster of the Pandemic has definitely brought about a spike in hair loss during the Pandemic. Part of it is due to the effects of the virus itself while the other part due to its emotional fallout.

However the good news is, that hair loss due to COVID-19 is not permanent and with the right combination of Homeopathy and US FDA approved Hair Vitalising treatment, hair can regrow back fully. Our hair doctors through a simple video microscopy test will get to the root of your hair issues and will start a plan of treatment to restore your hair naturally.”

https://www.drbatras.com/images/DrAkshayBatra.jpg

https://www.drbatras.com/images/Infographics_Hairloss_Covid19.jpg

Dr Batra’s clinics offer tailor-made instant to long-lasting solutions for hair loss that are based on the extent of the hair loss, grade of baldness, and condition of the hair and scalp. Qualified doctors and the winning mix of trichology, homoeopathy and aesthetic solutions has led to over 7 lakh happy hair patients with 96.6% success rate as accredited by American Quality Assessors.

Our hair treatment portfolio caters to all needs. The aesthetic treatment groHair is a non-surgical hair therapy that enhances hair fall control, improves hair volume and stimulates hair growth. While STMcell treatment is based on a French technology that increases hair volume and density.

Dr Batra’s Hair Vitalizing Treatment (HVT) stimulates hair regrowth and reduces hair breakage. Dr Batra’s NutriGood hair supplement is fortified with vitamin C, vitamin D, vitamin B complex and zinc. This hair nutrition supplement reduces hair loss, stimulate hair growth and enhance your hair quality. Dr Batra’s Geno Homeopathy treatment for hair loss is a gene-targeted homoeopathic therapy. It provides 99.9% accurate test results and can possibly also prevent heredity hair loss (androgenetic alopecia or male pattern baldness).

Get 10 sessions of U.S. FDA approved Hair Vitalizing Treatment free on registration of Dr Batra’s hair fall treatment.

About Dr Batra’s Homeopathy Clinics

With over 225 clinics in India, UK, UAE, Bahrain and Bangladesh, Dr Batra’s Homeopathy Clinics has over 400 doctors including skin specialist, hair specialist and experienced homoeopathic doctors. Dr Batra’s has treated over 1 million patients and been recognised as an ‘Icon of Indigenous Excellence in Healthcare’ by The Economic Times. Dr Batra’s specializes in Hair, Skin, Allergies, Child and Women’s Health, Mental Health, Sexual Health and Weight Management ailments including Hair Loss, Vitiligo, Psoriasis, Acne, Low immunity, Tonsillitis, Stress Management, Migraine, Thyroid, PCOS, Menopause, Allergies, Sexual Health and Weight Management, Infertility and Male Infertility.

Dr Batra’s explains the recently discovered link between COVID -19 and hairloss

Source

Recent Posts

Alopecia Treatment Market

Global Alopecia Drugs Market Report

Global Alopecia Drugs Market Report

The Alopecia Drugs market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Alopecia Drugs market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Alopecia Drugs market.

The report focuses on well-known providers in the global Alopecia Drugs industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Alopecia Drugs Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Alopecia Drugs market covered in Chapter 4

Dr. Reddy’s Laboratories Ltd
Cipla Inc.
Aqua Pharmaceuticals
Bayer HealthCare
Merck
Helix BioMedix
The Himalaya Drug Company
GlaxoSmithKline
Johnson & Johnson
AndroScience

In Chapter 11 and 13.3, on the basis of types, the Alopecia Drugs market from 2015 to 2026 is primarily split into:_x000D_

Oral
Topical
Injectable

In Chapter 12 and 13.4, on the basis of applications, the Alopecia Drugs market from 2015 to 2026 covers:

Men
Women

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Global Alopecia Drugs Market Report

Source

Recent Posts

Cost of a Bay Area Hair Transplant

Cost of a Bay Area Hair Transplant

Silicon Valley Hair Institute Announces Post on a Well-Rounded Perspective on the Cost of a Bay Area Hair Transplant

Silicon Valley Hair Institute, a best-in-class hair transplant clinic at siliconvalleyhairinstitute.com, is proud to announce a new post on the cost of a hair transplant in the Bay Area. The post argues for a well-rounded view of the cost of the procedure and emphasizes the emotional cost that thinning hair may evoke in some persons

“We understand that dealing with hair loss clinically can be a big step. The fear of the cost of hair transplant surgery could hold a person back. There are other ‘costs’ to ignoring the problem, however, such as how thinning hair hurts a person’s self-esteem,” explained Dr. Miguel Canales, hair loss surgeon for SVHI. “It’s important to look at the full picture and see how a thicker head of hair will boost confidence generating a positive return on investment.”

Interested persons can read the new post at https://siliconvalleyhairinstitute.com/cost-factors/. Individuals searching to combine thicker hair and younger-looking skin are also urged to review the sister website https://svaestheticderm.com/.

A personal plan for an overall fresher look may be the right strategy for the New Year as 2020 finally ends and we embark on a newer, better 2021.

BAY AREA RESIDENTS FIND POSITIVE RETURNS FROM HAIR TRANSPLANTATION

Here is the background on this release. Big-ticket items can seem out of reach to many Bay Area residents. If one reviews the full price of a home or car, it might seem overwhelming. Similarly, investing in one’s appearance can help with self-esteem and just make a person feel better about themselves.

For these reasons, Silicon Valley Hair Institute has announced a new post about the cost of a hair transplant in the Bay Area that argues for a well-rounded view of the procedure.

ABOUT SILICON VALLEY HAIR INSTITUTE

The Silicon Valley Hair Institute (http://siliconvalleyhairinstitute.com/), under the leadership of top-rated California hair transplant surgeon Miguel Canales MD, is one of the best facilities offering San Francisco Bay Area hair restoration. It is a professional team of San Francisco hair specialists led by Dr. Canales.

Dr. Canales provides the full range of advanced hair transplant and hair restoration procedures for Bay Area residents, from San Francisco to Palo Alto to San Jose. Treatments include; robotic hair transplants, FUE/FUT surgery, and micro-pigmentation. If one needs a hair transplant specialist, look no further than this Bay Area hair transplant center.

The clinic provides both San Jose FUE transplant and San Francisco FUE transplant services. Dr. Canales also performs female hair transplants for women and eyebrow restoration, thus offering the best hair transplant and robotic hair replacement options. Call today at 650-551-1100 for a no-cost consultation.

Silicon Valley Hair Institute Announces Post on a Well-Rounded Perspective on the Cost of a Bay Area Hair Transplant

Source

Recent Posts

LICHEN Professional

LICHEN Professional

Hair experts LICHEN Professional chose Cosmoprof Asia Digital Week to introduce their home-use products to the world

At Cosmoprof Asia Digital Week, the first ever digital edition of the region’s most renowned annual cosmetics and beauty event, LICHEN Professional responded to the current trend of home-use products with their hair colour and anti-hair loss products.

Super fast colour

With hairdressers currently unable to operate in some parts of the world, Lichen’s hair colour shampoo is the ideal stand in for those with black or brown hair. So easy to apply at home, it takes only five minutes to cover the hair with a colour that will last up to four weeks. As well as colouring the hair, the shampoo strengthens and nourishes each and every strand, as well as the roots. Once rinsed and dried, the hair looks shiny, feels silky and, just as importantly, boosts inner confidence once again.

Hair repair for anti-hair loss

Lichen’s Anti-Hair Loss Treatment is a combination of shampoo, conditioner, hair mask and hair oil. The 4-in-1 product makes it easy for anyone to stop having to worry about hair loss. Starting with a deep repair to the damaged hair, the product works to increase the health of the entire hair thanks to active precious plant essences as well as ingredients such as vitamin E, collagen and vitamin B5. The hair finish is nourished and moisturised on the inside and smooth, soft and bright on the outside.

About LICHEN Professional

Founded in 2010, Guangzhou LICHEN Cosmetic Co., Ltd is headquartered near the southern Chinese city’s airport. Focused on providing OEM hair care, LICHEN offers hair colour shampoo, as well as shampoo, conditioner, styling and treatment products. The company also works with clients on customised formulas for various requirements.

Comprising an FDA and ISO certified factory of 12,000 square meters, the company’s manufacturing space includes nine automatic process lines and a 400-square-meter lab, dedicated to ensuring the products that leave the factory are of the highest standard. The fast production line can handle minimum order quantities of testing trial orders as well as large-scale requests.

Lichen follows international standards throughout the process, and exports products to about 50 countries’ supermarkets, pharmacies, salons and stylists as well as to online stores. The company prides itself on its guarantee of quality, professional sales and after-sales services, and a team that creates these products with passion, efficiency and conscientiousness.

For product enquiry, please contact Anne Tang at 86-13538739819 or send an email to sales@lichenhaircolor.com.

About Cosmoprof Asia Digital Week

The first-ever edition of Cosmoprof Asia Digital Week has concluded successfully, creating copious business opportunities for the world’s companies and operators looking for new business solutions in the Asia-Pacific region.

652 exhibitors from 19 countries and regions took part in the event. 8,953 visitors from 115 countries and regions registered on the platform in order to virtually network, learn about current and upcoming trends. Cosmoprof Asia Digital Week offered a vital virtual business arena for the whole beauty industry while we are all waiting to meet again in Hong Kong in November 2021 for Cosmoprof Asia. Stay tuned for updates.

Hair experts LICHEN Professional chose Cosmoprof Asia Digital Week to introduce their home-use products to the world

Source

Recent Posts